Editorial neuroAIDS review.
作者信息
Shapshak Paul, Kangueane Pandjassarame, Fujimura Robert K, Commins Deborah, Chiappelli Francesco, Singer Elyse, Levine Andrew J, Minagar Alireza, Novembre Francis J, Somboonwit Charurut, Nath Avindra, Sinnott John T
出版信息
AIDS. 2011 Jan 14;25(2):123-41. doi: 10.1097/QAD.0b013e328340fd42.
Abstract
摘要
相似文献
1
Editorial neuroAIDS review.
AIDS. 2011 Jan 14;25(2):123-41. doi: 10.1097/QAD.0b013e328340fd42.
2
Central nervous system damage during HIV infection.
Methods Find Exp Clin Pharmacol. 1996 Dec;18(10):707-22.
3
HIV infection in non-human primates: the Macaca nemestrina model.
Virus Res. 1994 May;32(2):269-82. doi: 10.1016/0168-1702(94)90045-0.
4
Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008.
J Neuroimmune Pharmacol. 2009 Sep;4(3):283-97. doi: 10.1007/s11481-009-9159-1. Epub 2009 May 20.
5
Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis.
Am J Pathol. 2010 Dec;177(6):2938-49. doi: 10.2353/ajpath.2010.100536. Epub 2010 Nov 18.
6
Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome.
Ann Neurol. 1994 Oct;36(4):673-6. doi: 10.1002/ana.410360422.
7
[Cerebral changes and HIV infection. Diagnostic methods are continuously improved].
Lakartidningen. 1993 Nov 17;90(46):4092-3.
8
NeuroAIDS: retroviral pathology and drugs of abuse.
Adv Exp Med Biol. 2001;493:259-61. doi: 10.1007/0-306-47611-8_32.
9
Functional imaging of the AIDS dementia complex and the metabolic pathology of the HIV-1-infected brain.
Neuroimaging Clin N Am. 1997 Aug;7(3):431-45.
10
[HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
No To Shinkei. 2004 Apr;56(4):301-10.
引用本文的文献
1
Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
PLoS One. 2023 May 25;18(5):e0285761. doi: 10.1371/journal.pone.0285761. eCollection 2023.
2
Machine Learning Prediction and Phyloanatomic Modeling of Viral Neuroadaptive Signatures in the Macaque Model of HIV-Mediated Neuropathology.
Microbiol Spectr. 2023 Feb 27;11(2):e0308622. doi: 10.1128/spectrum.03086-22.
3
Methamphetamine signals transcription of IL1β and TNFα in a reactive oxygen species-dependent manner and interacts with HIV-1 Tat to decrease antioxidant defense mechanisms.
Front Cell Neurosci. 2022 Aug 18;16:911060. doi: 10.3389/fncel.2022.911060. eCollection 2022.
4
Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.
Neurotoxicology. 2022 Mar;89:140-160. doi: 10.1016/j.neuro.2022.02.002. Epub 2022 Feb 9.
5
Nose to brain delivery of Efavirenz nanosuspension for effective neuro AIDS therapy: , - and pharmacokinetic assessment.
Heliyon. 2021 Nov 11;7(11):e08368. doi: 10.1016/j.heliyon.2021.e08368. eCollection 2021 Nov.
6
From Anna University to America and to Agriculture.
Bioinformation. 2021 Jan 31;17(1):29-36. doi: 10.6026/97320630017029. eCollection 2021.
7
Impact of Tobacco Smoke in HIV Progression: a Major Risk Factor for the Development of NeuroAIDS and Associated of CNS Disorders.
Z Gesundh Wiss. 2020 Jun;28(3):259-270. doi: 10.1007/s10389-019-01062-8. Epub 2019 Mar 9.
8
Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV.
HIV AIDS (Auckl). 2020 Oct 13;12:559-572. doi: 10.2147/HIV.S260831. eCollection 2020.
9
Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment.
J Leukoc Biol. 2021 Mar;109(3):675-681. doi: 10.1002/JLB.5AB0420-531R. Epub 2020 Jun 24.
10
Cross-talk between microglia and neurons regulates HIV latency.
PLoS Pathog. 2019 Dec 30;15(12):e1008249. doi: 10.1371/journal.ppat.1008249. eCollection 2019 Dec.
本文引用的文献
1
Impact of Val158Met on executive functioning in the context of HIV and methamphetamine.
Neurobehav HIV Med. 2010 Jan 1;2010:1-11. doi: 10.2147/NBHIV.S8245.
2
A HLA-DRB supertype chart with potential overlapping peptide binding function.
Bioinformation. 2010 Jan 20;4(7):300-9. doi: 10.6026/97320630004300.
3
The renaissance in HIV vaccine development--future directions.
N Engl J Med. 2010 Jul 29;363(5):e7. doi: 10.1056/NEJMp1007629. Epub 2010 Jul 14.
4
CCL3 genotype and current depression increase risk of HIV-associated dementia.
Neurobehav HIV Med. 2009 Nov;1:1-7. doi: 10.2147/nbhiv.s6820.
5
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
Science. 2010 Aug 13;329(5993):856-61. doi: 10.1126/science.1187659. Epub 2010 Jul 8.
6
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
Science. 2010 Aug 13;329(5993):811-7. doi: 10.1126/science.1192819. Epub 2010 Jul 8.
7
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.
Nat Rev Immunol. 2010 Jul;10(7):527-35. doi: 10.1038/nri2801.
8
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.
BMC Neurol. 2010 Jun 17;10:44. doi: 10.1186/1471-2377-10-44.
9
Neurologic complications of HIV disease and their treatment.
Top HIV Med. 2010 Apr-May;18(2):45-55.
10
APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.
AIDS. 2010 Jun 19;24(10):1471-9. doi: 10.1097/QAD.0b013e328339e25c.
Zotero 插件